Crestwood Advisors Group LLC Reduces Stock Position in The Procter & Gamble Company (NYSE:PG)



Crestwood Advisors Group LLC reduced its position in shares of The Procter & Gamble Company (NYSE:PG – Get Rating) by 1.5% during the 1st quarter, Holdings Channel reports. The firm owned 160,923 shares of the company’s stock after selling 2,451 shares during the quarter. Crestwood Advisors Group LLC’s holdings in Procter & Gamble were worth $24,589,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Western Pacific Wealth Management LP acquired a new position in shares of Procter & Gamble in the 4th quarter valued at about $40,000. Delos Wealth Advisors LLC acquired a new position in Procter & Gamble in the 4th quarter worth about $50,000. Level Financial Advisors Inc. acquired a new position in Procter & Gamble in the 4th quarter worth about $51,000. LFA Lugano Financial Advisors SA acquired a new position in Procter & Gamble in the 4th quarter worth about $53,000. Finally, James Reed Financial Services Inc. acquired a new position in Procter & Gamble in the 4th quarter worth about $53,000. Institutional investors and hedge funds own 63.64% of the company’s stock.

Shares of PG opened at $138.50 on Thursday. The firm has a market cap of $332.30 billion, a P/E ratio of 24.17, a price-to-earnings-growth ratio of 3.74 and a beta of 0.40. The Procter & Gamble Company has a 12-month low of $129.50 and a 12-month high of $165.35. The company’s 50-day moving average price is $149.68 and its 200 day moving average price is $154.44. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.53.

Procter & Gamble (NYSE:PG – Get Rating) last issued its quarterly earnings data on Wednesday, April 20th. The company reported $1.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.05. The firm had revenue of $19.38 billion for the quarter, compared to analyst estimates of $18.69 billion. Procter & Gamble had a net margin of 18.33% and a return on equity of 32.39%. Procter & Gamble’s revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.26 EPS. Equities research analysts forecast that The Procter & Gamble Company will post 5.85 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, May 16th. Investors of record on Friday, April 22nd were issued a $0.9133 dividend. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.87. This represents a $3.65 annualized dividend and a yield of 2.64%. The ex-dividend date was Thursday, April 21st. Procter & Gamble’s payout ratio is 63.70%.

In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 334 shares of the business’s stock in a transaction dated Tuesday, April 26th. The shares were sold at an average price of $162.43, for a total transaction of $54,251.62. Following the sale, the chief accounting officer now directly owns 1,220 shares in the company, valued at $198,164.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman David S. Taylor sold 60,000 shares of the business’s stock in a transaction dated Thursday, April 21st. The stock was sold at an average price of $164.52, for a total transaction of $9,871,200.00. Following the sale, the chairman now owns 253,933 shares in the company, valued at $41,777,057.16. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 108,415 shares of company stock worth $17,777,055. 0.51% of the stock is owned by insiders.

PG has been the subject of a number of analyst reports. Credit Suisse Group upped their price target on Procter & Gamble from $140.00 to $150.00 and gave the stock a “neutral” rating in a report on Thursday, April 21st. Jefferies Financial Group increased their target price on Procter & Gamble from $179.00 to $185.00 in a report on Thursday, April 21st. Barclays lowered their price target on Procter & Gamble from $176.00 to $157.00 and set an “overweight” rating on the stock in a research note on Monday, May 23rd. Raymond James lifted their target price on shares of Procter & Gamble from $175.00 to $180.00 and gave the stock an “outperform” rating in a research note on Thursday, April 21st. Finally, Evercore ISI set a $170.00 target price on shares of Procter & Gamble in a research note on Monday. Six investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $163.80.

Procter & Gamble Profile (Get Rating)

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Get Rating).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)



Receive News & Ratings for Procter & Gamble Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Procter & Gamble and related companies with MarketBeat.com’s FREE daily email newsletter.

.

Leave a Comment